Marrakech Fertility Institute

19/05/2026

14/05/2026

13/05/2026

Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for the condition previously known as Polycystic O***y Syndrome (PCOS) — a change that accurately reflects the condition, which affects 1 in 8 women, or more than 170 million worldwide.

The changes follows 14 years of research and advocacy and the largest global engagement ever for a medical name change, with more than 22,000 survey responses, workshops with women who have lived experience, health professionals, and the involvement of 56 patient organisations and professional societies around the world, including the Society for Endocrinology.

The term PCOS focused on “cysts” and ovaries, even though women don’t have cysts. PMOS is a long term endocrine/ hormonal and metabolic condition, and the misunderstanding has contributed to delayed diagnosis, poor quality of care and lack of research and funding.

Women living with the condition led the call for change — and their voices matter ❤️ 86% of patients and 76% of health professionals support the name change.

The change to PMOS will improve understanding, awareness, earlier diagnosis, better care and more research.

We recognise that this change will take time and there is a 3 year transition period where both names will co-exist together - the work doesn’t stop here!

Resources in multiple languages available: https://bit.ly/3V85nPJ

Read the paper: https://bit.ly/3R0pIYw

27/04/2026

15/04/2026

10/04/2026